Concepedia

Jasmin Quandt

JQ

Statistics

Publications

15

Citations

4.4K

H-Index

13

Active since

2013

Affiliations

BioNTech (Germany)(Current)

Johannes Gutenberg University Mainz

University Medical Center of the Johannes Gutenberg University Mainz

Pfizer (United States)

Regeneron (United States)

Jasmin Quandt is an author at BioNTech (Germany) specializing in life sciences, immunology, and vaccinology.

Publications per year

2013–2023

15

Publications

15

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +16

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Uğur Şahin, Alexander Muik, Isabel Vogler et al. · Nature · 2021 · 833 citations · Full text

, , +10

A vaccine targeting mutant IDH1 induces antitumour immunity

Theresa Schumacher, Lukas Bunse, Stefan Pusch et al. · Nature · 2014 · 698 citations

, , +11

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

Jasmin Quandt, Alexander Muik, Nadine Salisch et al. · Science Immunology · 2022 · 225 citations · Full text

, , +17

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

Uğur Şahin, Alexander Muik, Isabel Vogler et al. · medRxiv · 2020 · 171 citations · Full text

, , +17

1–5 of 15